Toggle menu
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Page values for "Zolpidem"

From Pharmacopedia
More actions

"Medicines" values

1 row is stored for this page
FieldField typeValue
genericStringZolpidem (tartrate)
brandStringAmbien (IR), Ambien CR (biphasic-release), Edluar (sublingual), Intermezzo (low-dose sublingual for middle-of-night awakening), Zolpimist (oral spray)
structureFile
classesList of String, delimiter: ,[[:Category:Non-benzodiazepine hypnotics|Non-benzodiazepine hypnotic]] [[:Category:Sleep aids|Sleep aid]] [[:Category:Schedule IV controlled substances|Schedule IV controlled substance]]
mechanismString
usesString'"`UNIQ--vote-00000017-QINU`"', '"`UNIQ--vote-00000018-QINU`"', '"`UNIQ--vote-00000019-QINU`"'
starting_doseString'''5 mg PO at bedtime for women, 5-10 mg for men''' (per FDA's 2013 sex-specific dose reduction for women due to slower clearance). Ambien CR 6.25 mg women / 6.25-12.5 mg men. Intermezzo SL 1.75 mg women / 3.5 mg men
preparationsStringIR tablets 5, 10 mg; CR tablets 6.25, 12.5 mg; SL tablets 1.75, 3.5, 5, 10 mg; oral spray
fda_maxString10 mg/day (IR); 12.5 mg/day (CR)
pill_idText
routesList of String, delimiter: ,Oral sublingual oromucosal spray
onsetString15-30 minutes
durationString6-8 hours (IR); 8 hours (CR via biphasic release)
halflifeString~2.5 hours'"`UNIQ--ref-0000001A-QINU`"'
bioavailabilityString~70% (oral)'"`UNIQ--ref-0000001B-QINU`"'
pregnancyStringLimited human data; case reports of neonatal sedation with late-pregnancy exposure.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup>
legalString[[USLegal:Schedule IV|Schedule IV controlled substance]] in US. Carries the FDA '''Boxed Warning''' for '''complex sleep behaviors''' (sleep-driving, sleep-walking, sleep-eating, other parasomnias) added in 2019'"`UNIQ--ref-0000001C-QINU`"'